MLH1 p.Pro581=
c.1743G>A · rs567838745 · VCV185937
Conflicting classifications of pathogenicity
Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 14 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0156%, eas)
Conditions
4
hereditary neoplastic syndrome
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| REVEL | 0.013 | strongly benign-leaning |
|---|---|---|
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -9.8 | GERP -4.3 |
| Overall | ||
| CADD | 0.878 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
gnomAD v4.1 · exomes + genomes
Grpmax group
0.0156%
East Asian · 7/44,878 alleles
Filtering AF
0.00726%
ClinGen BA1/BS1 input
FAF95, joint · FAF99 0.00515%
Overall
0.00254%
41/1,614,078 alleles · ultra-rare
exomes 35/1,461,820 · genomes 6/152,258 · joint denominator
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.0156% | 6,411 |
| Admixed American | 0.01% | 10,002 |
| African / African-American | 0.00933% | 10,718 |
| South Asian | 0.00549% | 18,216 |
| Finnishnot grpmax-eligible | 0.00156% | 64,018 |
| European (non-Finnish) | 0.00127% | 78,665 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- MLH1
- Protein
- p.Pro581=
- Coding
- c.1743G>A
- MANE Select
- NM_000249
- dbSNP
- rs567838745
- Type
- single nucleotide variant
- Location
- chr3:37047530 (GRCh38)
- Gene constraint
- LOEUF 0.639 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 77.89 · 13 PDB
- Residue 581
- a UniProt-annotated variant site (in lynch2; decreased mismatch repair activity; defective in interaction with pms2); a β-strand; the 'interaction with exo1' region
Similar variants
- MLH1 p.Pro581Leu Likely benign ★★★ ⚠ same residue
- MLH1 p.Pro581Gln Uncertain significance ★ ⚠ same residue
- MLH1 p.Pro581fs Pathogenic/Likely pathogenic ★★ same residue
- MLH1 c.1038+1G>C Likely pathogenic ★★★ same condition
- MLH1 c.1039-1G>A Pathogenic ★★★ same condition
- MLH1 c.1039-2A>G Likely pathogenic ★★★ same condition
- MLH1 c.1039-2A>T Likely pathogenic ★★★ same condition
- MLH1 c.116+1G>A Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mlh1-p-pro581 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown